SCHEMBL24802482

SCHEMBL24802482

COc1ncc(C)cc1CCN(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC13A5 Q86YT5 3/20 0.49
SLC13A2 Q13183 1/20 0.49
SLC13A3 Q8WWT9 1/20 0.49
HTR2A P28223 3/20 0.41
CHRNA7 P36544 1/20 0.38
CYP2D6 P10635 2/20 0.37
HRH1 P35367 1/20 0.37
KCNH2 Q12809 1/20 0.37
HTR6 P50406 3/20 0.36
HTR3E A5X5Y0 1/20 0.36
HTR3B O95264 1/20 0.36
CYP1A2 P05177 1/20 0.36
HTR1A P08908 1/20 0.36
CYP2C9 P11712 1/20 0.36
HTR1D P28221 1/20 0.36
HTR1B P28222 1/20 0.36
HTR2C P28335 1/20 0.36
HTR1E P28566 1/20 0.36
HTR1F P30939 1/20 0.36
HTR7 P34969 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12093547 0.77 SLC13A5 (0.51) SLC13A5SLC13A2SLC13A3CYP2C9L3MBTL1
SCHEMBL24802441 0.76 HTR1A (0.40) HTR2AHTR6HTR1AHTR1DHTR1B
SCHEMBL24092341 0.75 SLC13A5 (0.47) SLC13A5SLC13A2SLC13A3CYP2C9
SCHEMBL20670339 0.75 SLC13A5 (0.47) SLC13A5SLC13A2SLC13A3CYP2C9
SCHEMBL5780686 0.75 SLC13A5 (0.50) SLC13A5SLC13A2SLC13A3CYP2C9
SCHEMBL5780868 0.75 SLC13A5 (0.50) SLC13A5SLC13A2SLC13A3CYP2C9
SCHEMBL29863385 0.73 HTR2A (0.41) HTR2ACYP2D6HRH1HTR6HTR3E
SCHEMBL21459468 0.73 HTR2A (0.41) HTR2ACYP2D6HRH1HTR6HTR3E
SCHEMBL24802457 0.73 SLC13A5 (0.49) SLC13A5SLC13A2SLC13A3
SCHEMBL2254432 0.73 SLC6A4 (0.40) HTR2ACYP2D6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022268209-A1 DERIVATIVE HAVING PYRIMIDINE-FUSED CYCLIC STRUCTURE, AND USE THEREOF 四川汇宇制药股份有限公司 2022-12-29 WO disclosed